Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
155 hedge funds and large institutions have $718M invested in Momenta Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 14 closing their positions.
268% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $524K
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
13% more capital invested
Capital invested by funds: $638M → $718M (+$79.9M)
6% more funds holding
Funds holding: 146 → 155 (+9)
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$12.8M |
| 2 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$7M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$6.97M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.78M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$5.82M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.58M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.79M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.71M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.62M |
MNTA Hedge Fund Activity: Q3 2016 in Review
155 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q3 2016, worth a combined $718M — up 13% from $638M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MNTA positions and 14 closed out — a net gain of 9 holders — while 52 added to existing stakes and 51 trimmed.
The largest buyer was Millennium Management, adding an estimated $12.8M. The largest seller was Numeric Investors, cutting an estimated $5.82M.
- 155 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q3 2016, up from 146 in Q2 2016.
- Funds reported $718M of Momenta Pharmaceuticals, Inc. stock for Q3 2016, up 13% quarter-over-quarter.
- 23 funds opened new Momenta Pharmaceuticals, Inc. positions in Q3 2016 and 14 closed out, a net change of +9 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q3 2016 was Millennium Management, an estimated $12.8M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q3 2016 was Numeric Investors, an estimated $5.82M sold.
Based on aggregated 13F filings for Q3 2016.